Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYBT | OSTX | CVM | ||
| Company | Zhengye Biotechnology Holding Limited | Os Therapies Incorporated | Cel-Sci Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NYSE Arca | ||
| Open | 0.8700 | 1.2000 | 4.95 | ||
| High | 0.9100 | 1.2100 | 5.14 | ||
| Low | 0.8500 | 1.1800 | 4.70 | ||
| Latest | 0.8800 | 1.1800 | 4.80 | ||
| Change | -0.0200 | -0.0200 | -0.04 | ||
| % Change | -2.22% | -1.67% | -0.83% | ||
| Volume | 9,500 | 200,000 | 61,100 | ||
| 20-Day Average Volume | 17,175 | 500,070 | 66,245 | ||
| Previous Close | 0.9000 | 1.2000 | 4.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9494 | 1.3105 | 5.31 | ||
| 20-Day Raw Stochastic | 33.86% | 8.11% | 10.14% | ||
| 20-Day Relative Strength | 35.04 | 36.82 | 43.76 | ||
| Weighted Alpha | -76.85 | -44.06 | -59.01 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.87% since 02/12/26 | +1.72% since 02/12/26 | +4.35% since 02/12/26 | ||
| Low | 0.7800 on 02/17/26 | 1.1500 on 02/19/26 | 4.58 on 02/17/26 | ||
| High | 1.0900 on 02/13/26 | 1.2500 on 02/13/26 | 5.20 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -20.00% since 01/20/26 | -21.33% since 01/20/26 | -8.57% since 01/20/26 | ||
| Low | 0.7201 on 02/05/26 | 1.1500 on 02/19/26 | 4.58 on 02/17/26 | ||
| High | 1.1924 on 02/10/26 | 1.5399 on 01/22/26 | 6.75 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -57.28% since 11/20/25 | -27.16% since 11/20/25 | -21.57% since 11/20/25 | ||
| Low | 0.7201 on 02/05/26 | 1.1500 on 02/19/26 | 4.01 on 12/22/25 | ||
| High | 2.4300 on 11/25/25 | 2.0850 on 12/10/25 | 7.80 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | -90.73% since 08/20/25 | -46.12% since 08/20/25 | -46.07% since 08/20/25 | ||
| Low | 0.7201 on 02/05/26 | 1.1500 on 02/19/26 | 4.01 on 12/22/25 | ||
| High | 13.0800 on 09/02/25 | 2.5700 on 08/22/25 | 13.48 on 08/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 41,506 | 41,553 | 40,598 | ||
| Shares Outstanding, K | 47,166 | 35,214 | 8,458 | ||
| Annual Sales | 25,530,000 | 0 | 0 | ||
| Annual Net Income | 1,550,000 | -8,880,000 | -25,410,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -6,880,000 | -6,100,000 | ||
| 60-Month Beta | N/A | -3.79 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.21 on 11/14/25 | -1.36 on 08/14/25 | ||
| Latest Earnings Date | 07/02/26 | 03/30/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||